S&P 500   4,594.62 (-2.27%)
DOW   34,899.34 (-2.53%)
QQQ   391.20 (-1.90%)
AAPL   156.81 (-3.17%)
MSFT   329.68 (-2.44%)
FB   333.12 (-2.33%)
GOOGL   2,843.66 (-2.69%)
AMZN   3,504.56 (-2.12%)
TSLA   1,081.92 (-3.05%)
NVDA   315.03 (-3.58%)
BABA   133.35 (-2.32%)
NIO   39.99 (-3.45%)
CGC   11.69 (-1.52%)
AMD   154.81 (-1.89%)
GE   97.84 (-4.29%)
MU   83.42 (-3.24%)
T   24.22 (-1.02%)
F   19.75 (-2.47%)
DIS   148.11 (-2.13%)
ACB   6.79 (+0.15%)
AMC   37.63 (-3.24%)
PFE   54.00 (+6.11%)
BA   199.21 (-5.41%)
S&P 500   4,594.62 (-2.27%)
DOW   34,899.34 (-2.53%)
QQQ   391.20 (-1.90%)
AAPL   156.81 (-3.17%)
MSFT   329.68 (-2.44%)
FB   333.12 (-2.33%)
GOOGL   2,843.66 (-2.69%)
AMZN   3,504.56 (-2.12%)
TSLA   1,081.92 (-3.05%)
NVDA   315.03 (-3.58%)
BABA   133.35 (-2.32%)
NIO   39.99 (-3.45%)
CGC   11.69 (-1.52%)
AMD   154.81 (-1.89%)
GE   97.84 (-4.29%)
MU   83.42 (-3.24%)
T   24.22 (-1.02%)
F   19.75 (-2.47%)
DIS   148.11 (-2.13%)
ACB   6.79 (+0.15%)
AMC   37.63 (-3.24%)
PFE   54.00 (+6.11%)
BA   199.21 (-5.41%)
S&P 500   4,594.62 (-2.27%)
DOW   34,899.34 (-2.53%)
QQQ   391.20 (-1.90%)
AAPL   156.81 (-3.17%)
MSFT   329.68 (-2.44%)
FB   333.12 (-2.33%)
GOOGL   2,843.66 (-2.69%)
AMZN   3,504.56 (-2.12%)
TSLA   1,081.92 (-3.05%)
NVDA   315.03 (-3.58%)
BABA   133.35 (-2.32%)
NIO   39.99 (-3.45%)
CGC   11.69 (-1.52%)
AMD   154.81 (-1.89%)
GE   97.84 (-4.29%)
MU   83.42 (-3.24%)
T   24.22 (-1.02%)
F   19.75 (-2.47%)
DIS   148.11 (-2.13%)
ACB   6.79 (+0.15%)
AMC   37.63 (-3.24%)
PFE   54.00 (+6.11%)
BA   199.21 (-5.41%)
S&P 500   4,594.62 (-2.27%)
DOW   34,899.34 (-2.53%)
QQQ   391.20 (-1.90%)
AAPL   156.81 (-3.17%)
MSFT   329.68 (-2.44%)
FB   333.12 (-2.33%)
GOOGL   2,843.66 (-2.69%)
AMZN   3,504.56 (-2.12%)
TSLA   1,081.92 (-3.05%)
NVDA   315.03 (-3.58%)
BABA   133.35 (-2.32%)
NIO   39.99 (-3.45%)
CGC   11.69 (-1.52%)
AMD   154.81 (-1.89%)
GE   97.84 (-4.29%)
MU   83.42 (-3.24%)
T   24.22 (-1.02%)
F   19.75 (-2.47%)
DIS   148.11 (-2.13%)
ACB   6.79 (+0.15%)
AMC   37.63 (-3.24%)
PFE   54.00 (+6.11%)
BA   199.21 (-5.41%)
LON:REL

Relx Share Forecast, Price & News

GBX 2,309
-41.00 (-1.74%)
(As of 11/26/2021 12:00 AM ET)
Add
Compare
Today's Range
2,275
2,334
50-Day Range
2,125
2,380
52-Week Range
1,484.90
2,634.82
Volume
3.79 million shs
Average Volume
2.45 million shs
Market Capitalization
£44.67 billion
P/E Ratio
33.37
Dividend Yield
2.03%
Beta
N/A
30 days | 90 days | 365 days | Advanced Chart
Receive REL News and Ratings via Email

Sign-up to receive the latest news and ratings for Relx and its competitors with MarketBeat's FREE daily newsletter.


Relx logo

About Relx

RELX PLC provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Scientific, Technical & Medical; Risk; Legal; and Exhibitions. The Scientific, Technical & Medical segment provides information and analytics that help institutions and professionals to progress in science and advance healthcare. The Risk segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicting risk. The Legal segment provides legal, regulatory, and business information and analytics that help customers in decision-making, as well as enhance the productivity. The Exhibitions segment is involved in the events business. The company was formerly known as Reed Elsevier PLC and changed its name to RELX PLC in July 2015. The company was incorporated in 1903 and is headquartered in London, the United Kingdom.

Headlines

Berenberg Bank Analysts Give Relx (LON:REL) a GBX 2,300 Price Target
November 23, 2021 |  americanbankingnews.com
Relx (LON:REL) Sets New 52-Week High at $2,634.82
November 22, 2021 |  americanbankingnews.com
Berenberg Bank Raises Relx (LON:REL) Price Target to GBX 2,300
November 18, 2021 |  americanbankingnews.com
Relx Plc (LON:REL) Receives Consensus Rating of "Buy" from Analysts
November 16, 2021 |  americanbankingnews.com
Relx (LON:REL) Sets New 1-Year High at $2,379.00
November 12, 2021 |  americanbankingnews.com
Relx (LON:REL) Given a GBX 2,135 Price Target at UBS Group
November 10, 2021 |  americanbankingnews.com
Relx (LON:REL) Sets New 12-Month High at $2,290.00
November 1, 2021 |  americanbankingnews.com
See More Headlines

Industry, Sector and Symbol

Industry
Publishing
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
33,200
Year Founded
N/A

Sales & Book Value

Annual Sales
£7.00 billion
Cash Flow
GBX 3.35 per share
Book Value
GBX 125.50 per share

Profitability

Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Outstanding Shares
1,934,622,000
Free Float
N/A
Market Cap
£44.67 billion
Optionable
Not Optionable

Company Calendar

Last Earnings
7/23/2020
Ex-Dividend
8/05/2021
Dividend Payable
9/08/2021
Today
11/26/2021
Next Earnings (Estimated)
2/09/2022

MarketRank

Overall MarketRank

1.92 out of 5 stars

Analyst Opinion: 1.4Community Rank: 4.9Dividend Strength: 1.7Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -












Relx (LON:REL) Frequently Asked Questions

Is Relx a buy right now?

10 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Relx in the last year. There are currently 3 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Relx stock.
View analyst ratings for Relx
or view top-rated stocks.

How has Relx's stock price been impacted by Coronavirus?

Relx's stock was trading at GBX 1,685 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, REL stock has increased by 37.0% and is now trading at GBX 2,309.
View which stocks have been most impacted by COVID-19
.

When is Relx's next earnings date?

Relx is scheduled to release its next quarterly earnings announcement on Wednesday, February 9th 2022.
View our earnings forecast for Relx
.

How were Relx's earnings last quarter?

Relx Plc (LON:REL) released its earnings results on Thursday, July, 23rd. The company reported $37.00 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $36.60 by $0.40.
View Relx's earnings history
.

How often does Relx pay dividends? What is the dividend yield for Relx?

Relx announced a dividend on Thursday, July 29th. Shareholders of record on Thursday, August 5th will be paid a dividend of GBX 14.30 per share on Wednesday, September 8th. This represents a yield of 0.68%. The ex-dividend date is Thursday, August 5th. The official announcement can be viewed at this link.
View Relx's dividend history
.

Is Relx a good dividend stock?

Relx pays an annual dividend of GBX 0.47 per share and currently has a dividend yield of 2.03%. The dividend payout ratio of Relx is 0.68%. This payout ratio is at a healthy, sustainable level, below 75%.
View Relx's dividend history.

What price target have analysts set for REL?

10 brokers have issued 12-month price targets for Relx's stock. Their forecasts range from GBX 2,100 to GBX 2,540. On average, they expect Relx's stock price to reach GBX 2,331.33 in the next year. This suggests a possible upside of 1.0% from the stock's current price.
View analysts' price targets for Relx
or view top-rated stocks among Wall Street analysts.

Who are Relx's key executives?

Relx's management team includes the following people:
  • Mr. Erik Engstrom, CEO & Exec. Director (Age 58, Pay $3.55M)
  • Mr. Nicholas Lawrence Luff, CFO & Exec. Director (Age 54, Pay $1.89M)
  • Ms. Kumsal Bayazit Besson, Chief Exec. Officer of Scientific, Technical & Medical (Age 47)
  • Mr. Colin Tennant, Head of Investor Relations
  • Mr. Henry Adam Udow, Chief Legal Officer & Company Sec. (Age 63)
  • Mr. Paul Abrahams, Head of Corp. Communications
  • Ms. Jelena Sevo, Chief Strategy Officer
  • Mr. Michael Walsh, Chief Exec. Officer of Legal
  • Mr. Hugh M. Jones IV, Chief Exec. Officer of Exhibitions
  • Mr. Vijay Raghavan, Chief Technology Officer of Risk

What other stocks do shareholders of Relx own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Relx investors own include Unilever (ULVR), Barclays (BARC), Diageo (DGE), Standard Chartered (STAN), GlaxoSmithKline (GSK), HSBC (HSBA), Prudential (PRU), Aviva (AV), Imperial Brands (IMB) and Reckitt Benckiser Group (RB).

What is Relx's stock symbol?

Relx trades on the London Stock Exchange (LON) under the ticker symbol "REL."

How do I buy shares of Relx?

Shares of REL and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Relx's stock price today?

One share of REL stock can currently be purchased for approximately GBX 2,309.

How much money does Relx make?

Relx has a market capitalization of £44.67 billion and generates £7.00 billion in revenue each year.

How many employees does Relx have?

Relx employs 33,200 workers across the globe.

What is Relx's official website?

The official website for Relx is www.relx.com.

Where are Relx's headquarters?

Relx is headquartered at 1-3 Strand, LONDON, 00000, United Kingdom.

How can I contact Relx?

Relx's mailing address is 1-3 Strand, LONDON, 00000, United Kingdom. The company can be reached via phone at +44-20-71665500.


This page was last updated on 11/26/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.